Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent-Reference-Cited by-同舟云学术

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent

Published:2022-04-06 Issue:7 Volume:99 Page:1965-1975
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Jakobsen Lars¹^ORCID,Christiansen Evald H.¹,Freeman Phillip²,Kahlert Johnny³,Veien Karsten⁴,Maeng Michael¹,Raungaard Bent²,Ellert Julia⁴,Kristensen Steen D.¹,Christensen Martin K.²,Terkelsen Christian J.¹,Thim Troels¹,Eftekhari Ashkan¹²,Jensen Rebekka V.¹^ORCID,Støttrup Nicolaj B.¹,Junker Anders⁴,Hansen Henrik S.⁴,Jensen Lisette O.⁴

Affiliation:

1. Department of Cardiology Aarhus University Hospital Aarhus Denmark

2. Department of Cardiology Aalborg University Hospital Aalborg Denmark

3. Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark

4. Department of Cardiology Odense University Hospital Odense Denmark

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30175

Reference28 articles.